Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial

dc.contributor.author	Quintero Aldana, Guillermo
dc.contributor.author	Salgado Fernández, Mercedes
dc.date.accessioned	2017-06-07T07:02:07Z
dc.date.available	2017-06-07T07:02:07Z
dc.date.issued	2013
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1895
dc.language.iso	eng
dc.title	Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial
dc.type	Publicación de congreso
dc.authorsophos	Fernández, J.
dc.authorsophos	Cirera, L.
dc.authorsophos	Pericay, C.
dc.authorsophos	Saigi, E.
dc.authorsophos	Alonso, V.
dc.authorsophos	Quintero, G.
dc.authorsophos	Salud, A.
dc.authorsophos	Mendez, M.
dc.authorsophos	Salgado, M.
dc.identifier.isi	326843603448
dc.identifier.sophos	12377
dc.issue.number	S2
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ourense - Complexo Hospitalario Universitario de Ourense::Oncoloxía médica
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Lugo - Hospital Universitario Lucus Augusti::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	49

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.